Clinical Trial: Identification of Tumour-Infiltrating Regulatory T-Cell (Treg)-Related Glucose Metabolism Genes in Pancreatic Carcinoma and Construction of a Novel Machine Learning-Based Survival Predictive Signature (China)

Posted On: 2026-11-10

China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Identification of Tumour-Infiltrating Regulatory T-Cell (Treg)-Related Glucose Metabolism Genes in Pancreatic Carcinoma and Construction of a Novel Machine Learning-Based Survival Predictive Signature'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136295

Registration Time: 2026/11/09

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351825

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Identification of Tumour-Infiltrating Regulatory T-Cell (Treg)-Related Glucose Metabolism Genes in Pancreatic Carcinoma and Construction of a Novel Machine Learning-Based Survival Predictive Signature (China)